»Ê¼Ò»ªÈË

RCPCH responds to NHS England review of gender identity development services

NHSE is conducting a review of the specification for this service and associated policies for 2020. It will also set up an independent expert group to make recommendations regarding the use of puberty suppressants and cross-sex hormones.

Dr Michael Linney, Registrar at the RCPCH, commented:

We very much welcome the review of services, which provide support for young people and their families, and also the setting up of an independent expert group to inform best practice in the use of puberty suppressants and cross-sex hormones. This will be chaired by a former President of the Royal College of Paediatrics and Child Health, Dr Hilary Cass OBE, and will include both medical and non-medical experts.

We’re particularly pleased that NICE will feed into the work of this group by conducting a thorough review of the latest clinical evidence in this fast-moving area.